• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经管缺陷血清筛查服务的效果:南威尔士的经验

The efficacy of a serum screening service for neural-tube defects: the South Wales experience.

作者信息

Roberts C J, Hibbard B M, Elder G H, Evans K T, Laurence K M, Roberts A, Woodhead J S, Robertson I B, Hoole M

出版信息

Lancet. 1983 Jun 11;1(8337):1315-8. doi: 10.1016/s0140-6736(83)92424-8.

DOI:10.1016/s0140-6736(83)92424-8
PMID:6190057
Abstract

Serum-alpha-fetoprotein (AFP) levels were measured in more than 15 000 pregnant women in an investigation designed to examine the operational issues entailed in a large-scale population screening programme for antenatal detection of neural-tube defects. The proportion of open neural-tube defects (ONTD) terminated as a result of serum screening was 56.1% (66.6% for anencephaly and 40.7% for open spina bifida). The principle causes of poor efficacy were: failure of pregnant women to undergo screening (18.2% of ONTD were not screened); failure of the screening test to detect ONTD (20.4% of those screened were below the 90th centile); decisions against termination of detected ONTD (14% of ONTD detected by serum AFP were not terminated). Given present practices and knowledge it is doubtful whether overall efficacy levels above 65% for open spina bifida can be achieved under normal service conditions. The establishment of a regional or national screening programme on grounds of clinical efficacy alone may be premature. The decision would seem to hinge principally around a careful consideration of the economic issues.

摘要

在一项旨在检查大规模人群筛查计划中有关产前检测神经管缺陷的操作问题的调查中,对超过15000名孕妇进行了血清甲胎蛋白(AFP)水平检测。因血清筛查而终止妊娠的开放性神经管缺陷(ONTD)比例为56.1%(无脑儿为66.6%,开放性脊柱裂为40.7%)。疗效不佳的主要原因是:孕妇未接受筛查(18.2%的ONTD未接受筛查);筛查试验未能检测出ONTD(20.4%接受筛查的孕妇低于第90百分位数);决定不终止检测出的ONTD(血清AFP检测出的ONTD中有14%未被终止妊娠)。鉴于目前的做法和知识水平,在正常服务条件下,开放性脊柱裂的总体疗效水平能否超过65%令人怀疑。仅基于临床疗效建立区域或国家筛查计划可能为时过早。这一决定似乎主要取决于对经济问题的仔细考虑。

相似文献

1
The efficacy of a serum screening service for neural-tube defects: the South Wales experience.神经管缺陷血清筛查服务的效果:南威尔士的经验
Lancet. 1983 Jun 11;1(8337):1315-8. doi: 10.1016/s0140-6736(83)92424-8.
2
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.基于人群的神经管缺陷产前筛查中超声检查和血清甲胎蛋白的敏感性。南澳大利亚,1986 - 1991年。
Br J Obstet Gynaecol. 1995 May;102(5):370-6. doi: 10.1111/j.1471-0528.1995.tb11287.x.
3
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.妊娠早期羊水中甲胎蛋白测定在无脑儿和开放性脊柱裂产前诊断中的应用。英国神经管缺陷相关甲胎蛋白协作研究的第二次报告。
Lancet. 1979 Sep 29;2(8144):651-62.
4
Can we afford screening for neural tube defects? The South Wales experience.我们能否承担神经管缺陷筛查的费用?南威尔士的经验。
Br Med J (Clin Res Ed). 1985 Jan 26;290(6464):293-5. doi: 10.1136/bmj.290.6464.293.
5
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.孕早期产前筛查无脑儿和脊柱裂时母体血清甲胎蛋白测定。英国甲胎蛋白与神经管缺陷相关协作研究报告。
Lancet. 1977 Jun 25;1(8026):1323-32.
6
The use of maternal serum AFP in screening for neural tube defects.母体血清甲胎蛋白在神经管缺陷筛查中的应用。
UCLA Forum Med Sci. 1978;20:191-7.
7
[Prenatal alpha fetoprotein screening for defects in the neural tube].[神经管缺陷的产前甲胎蛋白筛查]
Schweiz Med Wochenschr. 1978 Aug 26;108(34):1302-7.
8
Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.双胎妊娠开放性神经管缺陷的母血清甲胎蛋白筛查
Prenat Diagn. 1990 Feb;10(2):71-7. doi: 10.1002/pd.1970100202.
9
Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.1985年英格兰和威尔士神经管缺陷的产前筛查与诊断
Prenat Diagn. 1989 Jun;9(6):393-400. doi: 10.1002/pd.1970090604.
10
Human benefits and costs of a national screening programme for neural-tube defects.全国神经管缺陷筛查计划对人类的益处与成本
Lancet. 1978 Dec 16;2(8103):1293-6. doi: 10.1016/s0140-6736(78)92053-6.

引用本文的文献

1
Ethics, justification and the prevention of spina bifida.伦理学、正当理由与脊柱裂的预防
J Med Ethics. 2007 Sep;33(9):501-7. doi: 10.1136/jme.2006.018697.
2
Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.定期健康检查,1994年更新版:3. 神经管缺陷的一级和二级预防。加拿大定期健康检查特别工作组。
CMAJ. 1994 Jul 15;151(2):159-66.
3
Which prescriptive screening programmes are worth while?哪些规范性筛查项目是值得开展的?
J Epidemiol Community Health. 1984 Dec;38(4):270-7. doi: 10.1136/jech.38.4.270.
4
Can we afford screening for neural tube defects? The South Wales experience.我们能否承担神经管缺陷筛查的费用?南威尔士的经验。
Br Med J (Clin Res Ed). 1985 Jan 26;290(6464):293-5. doi: 10.1136/bmj.290.6464.293.
5
Can we afford screening for neural tube defects.我们能否负担得起神经管缺陷的筛查费用?
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):711-2. doi: 10.1136/bmj.290.6469.711-c.
6
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.用于神经管缺陷的母血清甲胎蛋白筛查。德国一项联合研究的报告及神经管缺陷低出生患病率人群筛查的简短概述。
Hum Genet. 1985;69(1):47-61. doi: 10.1007/BF00295529.
7
A study of the value of measuring maternal serum alpha-fetoprotein for the antenatal diagnosis of neural tube defects.一项关于测定母血甲胎蛋白在神经管缺陷产前诊断中的价值的研究。
Arch Gynecol Obstet. 1989;244(3):133-6. doi: 10.1007/BF00931289.
8
Should women at high risk of neural tube defect have an amniocentesis?神经管缺陷高危女性应该做羊水穿刺检查吗?
J Med Genet. 1985 Dec;22(6):457-61. doi: 10.1136/jmg.22.6.457.
9
Neural tube defects--prenatal diagnosis and management.神经管缺陷——产前诊断与处理
Ulster Med J. 1992 Oct;61(2):127-33.